MedPath

Effect of raladi lepa in dadru kushta (tinea corporis)

Phase 3
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2024/08/072118
Lead Sponsor
Dr Roshan Shrikrushna Sarap
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient fulfilling the diagnostic criteria with classical sign and symptom of dadru kushta like kandu, mandal and raaga.parents willing to participate of their child and ready to give consent . children between the age group of 5 - 16 years. Patient will be selected irrespective of sex, religion, socioeconomic status.

Exclusion Criteria

Infected / pus discharging lesion. Patient suffering from chronic or systemic illness.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in signs and symptom of dadru kushta after application of Raladi lepa.Timepoint: 14 days
Secondary Outcome Measures
NameTimeMethod
Where the trial group stands in comparison with control group.Timepoint: 18 months.
© Copyright 2025. All Rights Reserved by MedPath